[Hypothyreotic connatal struma after amniofetography (author's transl)]

Newborns with hypothyroidism often face delayed diagnosis and treatment. Prior research has shown that maternal iodine exposure can affect fetal thyroid development. However, the specific impact of high-dose iodinated drugs during pregnancy remains unclear. This gap motivated a closer look at rare cases of neonatal thyroid dysfunction. No prior work had resolved the exact mechanism behind iodine-induced thyroid enlargement. The connection between amniofetography and thyroid issues is not well established. This paper explores an unusual clinical scenario involving iodine exposure and thyroid enlargement. The need to understand this link arises from the potential for preventable complications.

This case report aims to describe a newborn with hypothyroidism and goitre following maternal amniofetography. The specific problem is the lack of awareness about iodinated drugs' effects on fetal thyroid. The motivation is to highlight a rare but serious consequence of high-dose iodine exposure. The authors focus on a single case to illustrate potential risks. They aim to warn against the use of iodine-rich drugs during pregnancy. The study seeks to contribute to the understanding of thyroid pathophysiology. It also emphasizes the importance of monitoring thyroid function in neonates. The goal is to raise awareness among clinicians and obstetricians.

The authors present a clinical case study of a single newborn. Data was collected from medical records and clinical observations. The patient's thyroid hormone levels were measured over eight months. Respiratory difficulties led to intubation and thyroid hormone treatment. The goitre's size was monitored through physical examination. Laboratory tests tracked thyroid function and hormone levels. The study does not include statistical analysis or comparative data. The focus is on clinical progression and treatment outcomes.

The newborn exhibited severe hypothyroidism and a large goitre at birth. Iodinated drugs were used during the 22nd week of pregnancy. The goitre caused respiratory obstruction requiring intubation. Thyroid hormone treatment was administered for eight months. After discontinuation, thyroid function normalized within six months. The goitre size decreased significantly during treatment. No residual thyroid dysfunction was observed post-treatment. The findings suggest a direct link between iodine exposure and thyroid enlargement.

The authors conclude that high-dose iodinated drugs during pregnancy may lead to neonatal hypothyroidism. The case suggests a possible mechanism of thyroid suppression. They emphasize the importance of monitoring thyroid function in affected infants. The study warns against the use of iodine-rich drugs for amniofetography. The findings do not establish causation but suggest a correlation. The authors propose further research to clarify the pathogenesis. They recommend caution in clinical practice regarding iodine exposure. The study highlights the need for awareness among medical professionals.